We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT05001737
Brief Title: Evaluate Efficacy, Safety and Tolerability, PK and PD of Emapalumab in Children and Adults With MAS in Still's or SLE (EMERALD)

First Submitted : June 16, 2021
First Submitted that Met QC Criteria : August 3, 2021
First Posted : August 12, 2021

Last Update Submitted that Met QC Criteria : February 17, 2023
Last Update Posted : February 21, 2023